Regulatory Strategy 2030: AI Act, Digital Evidence, Data Spaces and Real-Time Compliance episode artwork

EPISODE · Jul 14, 2026 · 19 MIN

Regulatory Strategy 2030: AI Act, Digital Evidence, Data Spaces and Real-Time Compliance

from Center of Excellence - Pharma 4.0 by Dr. Jayant Joshi · host Dr. Jayant Joshi

Regulatory Strategy 2030: AI Act, Digital Evidence, Data Spaces and Real-Time Compliance The pharmaceutical regulatory landscape is undergoing its biggest transformation in decades. Traditional, document-based compliance is giving way to continuous, AI-enabled, real-time regulatory intelligence. In this episode of Center of Excellence - Pharma 4.0, we explore how pharmaceutical organizations must prepare for Regulatory Strategy 2030 by integrating AI governance, trusted digital evidence, health data ecosystems, and continuous compliance into every stage of the product lifecycle. In this episode, you will learn: Why static regulatory submissions are becoming obsolete How AI is transforming regulatory strategy and decision-making The impact of the EU AI Act and emerging global AI regulations Building AI governance frameworks with transparency and explainability The growing importance of digital evidence and real-world data Health Data Spaces and secure data-sharing ecosystems Trusted evidence architecture, data lineage, and interoperability Real-time compliance using predictive quality monitoring Human oversight and accountability in AI-enabled regulatory processes ICH Q12 and lifecycle regulatory agility A practical 90-day roadmap for regulatory transformation Developing future-ready regulatory capabilities through Pharma 4.0 and AI-driven learning Key Takeaway By 2030, regulatory compliance will no longer be a periodic activity—it will become a continuous, intelligent, and data-driven capability. Organizations that embed AI governance, trusted digital evidence, and real-time compliance into their operating model will be better positioned to accelerate innovation, strengthen regulatory confidence, and improve patient outcomes. Resources: Book Series: Center of Excellence – Pharma 4.0 https://www.amazon.com/dp/B0F1DX4XXB Udemy Course: Smart Manufacturing in Pharma https://www.udemy.com/course/smart-manufacturing-in-pharma/ Subscribe to our YouTube channel https://www.youtube.com/@COE-PHARMA4.0 Website: https://respa.com and follow the Podcast https://pharma4coe.podbean.com for more insights on the future of Pharma! #Pharma40 #RegulatoryStrategy2030 #AIAct #RegulatoryAffairs #DigitalEvidence #RealTimeCompliance #LifeSciences #PharmaceuticalIndustry #ArtificialIntelligence #HealthData #DataGovernance #DigitalTransformation #QualityManagement #Compliance #FDA #EMA #ICHQ12 #DigitalHealth #PharmaInnovation #CenterOfExcellence  

Episode metadata supplied by the publisher feed · Published Jul 14, 2026

Embed this episode

NOW PLAYING

Regulatory Strategy 2030: AI Act, Digital Evidence, Data Spaces and Real-Time Compliance

0:00 19:14

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Center of Excellence - Pharma 4.0 by Dr. Jayant Joshi?

This episode is 19 minutes long.

When was this Center of Excellence - Pharma 4.0 by Dr. Jayant Joshi episode published?

This episode was published on July 14, 2026.

Can I download this Center of Excellence - Pharma 4.0 by Dr. Jayant Joshi episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!